RPG Life Sciences Ltd

NSE: RPGLIFE · BSE: 532983 · Pharmaceuticals & Biotechnology · 46 announcements

Share price: ₹2,606.20
Market cap: ₹4,310 Cr
Revenue (annual): ₹707.5 Cr
Net profit (annual): ₹115.2 Cr
P/E (TTM): 39.4×Sector 43.8×
Promoter holding: 72.95%+0.00% QoQ
FII holding: 0.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Oct 2026 17:44 IST NSE

Earnings Call

RPG Life Sciences Earnings Call Transcript: Key Takeaways

RPG Life Sciences delivered record quarterly revenue exceeding ₹200 Cr, driven by volume-led growth in domestic formulations and strategic API acquisitions. Management maintains a focus on premiumization and operational efficiency despite West Asia supply headwinds.

Call: Guides 25% growth

Open call summary → Read the filing ↗

29 Oct 2026 23:24 IST BSE

Earnings Call

RPG Life Sciences Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹211.6 cr (+16.5%), adj PAT ₹32.3 cr (+13.4%), PAT margin 15.3%. API sales up 89%; domestic formulations +11.6%, international +6.4%.

Open call summary → Read the filing ↗